Statistics on Biotechnology Use  
Results by sector of operation
Total sectors. Biotechnology results by main variables and fields of operation. 
Unidades: specified in variables

;Total;Units;P.A.;Higher Education;PNPI;
Units that perform R+D in Biotechnology;1.256;1.056;123;66;11;
%Units according to biotechnology used: Genetic code;44;36;90;86;55;
%Units according to biotechnology used: Functional units;52;45;90;92;46;
%Units according to biotechnology used: Cellular and tissue culturing and engineering;35;27;76;80;73;
%Units according to biotechnology used: Bioprocesses;50;47;59;88;46;
%Units according to biotechnology used: Sub-cellular organisms;17;8;56;68;36;
%Units according to biotechnology used: Bio-computing;32;25;71;83;27;
%Units according to biotechnology used: Nanobiotechnology;20;13;50;73;9;
%Units according to biotechnology used: Other;14;15;9;14;9;
Units in which biotechnology activities are:  Main and/or exclusive;598;551;34;4;9;
Units in which biotechnology activities are: A secondary line of business;265;183;38;43;1;
Units in which biotechnology activities are: A tool necessary for production;394;323;51;19;1;
%Units by field(s) of ultimate application of biotechnology use: Human health;54;49;80;91;73;
%Units by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;22;20;16;62;9;
%Units by field(s) of ultimate application of biotechnology use: Food products;32;30;20;83;0;
%Units by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;25;23;19;70;18;
%Units by field(s) of ultimate application of biotechnology use: Environment;17;13;24;71;9;
%Units by field(s) of ultimate application of biotechnology use: Industry;15;12;12;68;9;
Personnel in R&D in biotechnology (no. of persons);38.311;10.719;13.881;13.355;356;
Personnel in R&D in biotechnology (no. of persons): Researchers;25.082;6.131;8.130;10.534;287;
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;13.229;4.588;5.751;2.821;69;
Personnel in R&D in biotechnology (no. of persons): women;21.567;6.040;8.575;6.734;218;
Personnel in R&D in biotechnology (no. of persons): (women) Researchers;13.264;3.411;4.624;5.057;172;
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;8.303;2.629;3.951;1.677;46;
Personnel in R&D in biotechnology (FTE);26.692,1;7.750,8;10.337,9;8.497,2;106,2;
Personnel in R&D in biotechnology (FTE): Researchers;16.693,3;4.518,1;5.616,2;6.496,1;62,9;
Personnel in R&D in biotechnology (FTE): Technicians and assistants;9.998,8;3.232,7;4.721,7;2.001,1;43,3;
Personnel in R&D in biotechnology (FTE): women;15.343,5;4.471,4;6.461,1;4.337,4;73,6;
Personnel in R&D in biotechnology (FTE): (women) Researchers;9.002,9;2.562,7;3.249,3;3.148;42,9;
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;6.340,6;1.908,7;3.211,8;1.189,4;30,7;
Internal expenditure on R&D (thousands of euros);1.693.773;679.558;610.723;397.671;5.821;
1) By nature of the expense: Current expenses;1.585.388;634.631;574.604;370.428;5.723;
1.1) Remuneration to researchers;659.430;228.857;210.344;218.729;1.501;
1.2) Remuneration to technicians and assistants;278.456;104.498;118.726;54.188;1.044;
1.3) Other current expenses;647.501;301.276;245.535;97.512;3.178;
2) By nature of the expense: Capital expenses;108.386;44.927;36.118;27.243;98;
2.1) Land and buildings;13.514;2.585;5.020;5.909;0;
2.2) Equipment and instruments;73.707;23.569;30.028;20.012;98;
2.3) Acquisition of specific R+D software;3.621;1.392;992;1.237;0;
2.4) Otros productos de propiedad intelectual específicos para I+D;17.544;17.381;78;85;0;
1) By origin of the funds: National funds;1.456.745;556.297;546.727;348.357;5.365;
1.1) Own funds;597.793;387.010;135.388;74.853;541;
1.2) From companies;171.566;86.025;50.625;32.844;2.073;
1.3) Public Administration funds;638.127;74.764;329.591;232.956;816;
1.4) From Universities;2.780;408;1.808;535;29;
1.5) From non profit private institutions;46.480;8.090;29.315;7.170;1.906;
1) By origin of the funds: Foreign funds;237.028;123.262;63.996;49.314;456;
2.1) From EU programmes;119.838;25.125;52.212;42.501;0;
2.2) Other foreign funds;117.190;98.137;11.784;6.813;456;
Purchase of services R & D in Biotechnology to (thousands of euros);177.895;147.558;26.353;3.597;386;
Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;105.337;76.875;24.581;3.554;326;
Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;72.558;70.683;1.772;43;60;
%Units that consider the following obstacles as very important considering biotechnology development: Access to capital;50;49;58;53;73;
%Units that consider the following obstacles as very important considering biotechnology development: Access to technology / information;13;14;7;8;27;
%Units that consider the following obstacles as very important considering biotechnology development: Access to human resources;20;16;42;41;27;
%Units that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;15;13;27;30;18;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;20;18;33;36;18;
%Units that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;20;18;29;36;36;
%Units that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;16;17;9;11;18;
%Units that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;37;37;39;30;46;
%Units that consider the following obstacles as very important considering biotechnology development: Time / cost;52;51;54;58;55;
%Units that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;18;18;20;14;27;
%Units that have requested biotechnology patents in Biotechnology;21;15;43;74;0;
Number of patents requested;1.770;746;539;485;0;
Notas:
'..'=data not available 

 '.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent 

 (*) Total calculated from the total number of companies with related activities  with Biotechnology and the total units from other sectors with activities  in R&D in Biotechnology
Fuente: National Statistics Institute